富瑞:料百度(9888.HK)上季核心收入升8% 維持“買入”評級
富瑞發研報指,預期百度(9888.HK)第四季恢復至其指引軌道上,考慮到新冠疫情對廣吿的影響等因素令第一季存不確定性,料其廣吿業務將於第二季復甦,而云服務及智能駕駛業務則可保持強勁增長勢頭。該行維持其“買入”評級,予目標價262港元。
富瑞預期,百度第四季核心收入按年升8%,符合指引範圍;非通用會計準則營業利潤率方面,預期核心營業利潤率預測14%。該行續指,百度與吉利(0175.HK)合資的集度汽車計劃在今年上半年公佈首部概念車,並於2023年大規模生產及交付,另外百度亦獲批在北京營運其自動駕駛汽車服務。至於人工智能業務,該行預期將可維持穩健增長趨勢。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.